SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics

Go back to SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
(NASDAQ: YMAB) Delayed: 8.61 --0 (-0%)
Previous Close $8.61    52 Week High
Open $8.61    52 Week Low
Day High $8.61    P/E N/A 
Day Low $8.61    EPS
Volume 5,034,571